<DOC>
	<DOCNO>NCT01745159</DOCNO>
	<brief_summary>To assess proactive , 2 times-weekly application tacrolimus ointment extend remission time relapse reduce incidence disease exacerbation ( DE ) paediatric patient period 6 month .</brief_summary>
	<brief_title>Preventive Treatment Tacrolimus Ointment Children With Atopic Dermatitis</brief_title>
	<detailed_description>This study include three period . First screen period one week . Second open-label treatment period six week participant apply tacrolimus ointment . Third open-label disease control period six month half participant apply tacrolimus ointment half participant apply treatment .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>1 . Diagnosed AD accord Williams diagnostic criterion . 2 . Moderate severe atopic dermatitis accord criterion Rajka Langeland 3 . At least approximately 10 % body area 4 . Patient able reach centre within 3 day case disease exacerbation . 5 . Patient ` legal representative ( ) has/have give write informed consent . If patient capable understanding purpose risk trial , write informed consent obtain patient well</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>tacrolimus</keyword>
	<keyword>Protopic</keyword>
	<keyword>pediatric</keyword>
	<keyword>atopic dermatitis</keyword>
	<keyword>China</keyword>
</DOC>